Tudor Investment Corp’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-90,270
| Closed | -$544K | – | 1477 |
|
|
2019
Q4 | $544K | Sell |
90,270
-92,168
| -51% | -$533K | 0.02% | 692 |
|
|
2019
Q3 | $657K | Buy |
182,438
+110,879
| +155% | +$427K | 0.02% | 628 |
|
|
2019
Q2 | $192K | Buy |
71,559
+54,531
| +320% | +$161K | 0.01% | 979 |
|
|
2019
Q1 | $50K | Sell |
17,028
-61,734
| -78% | -$152K | ﹤0.01% | 1052 |
|
|
2018
Q4 | $125K | Buy |
78,762
+41,359
| +111% | +$117K | ﹤0.01% | 910 |
|
|
2018
Q3 | $138K | Buy |
+37,403
| New | +$111K | ﹤0.01% | 1002 |
|
|
2018
Q1 | – | Sell |
-245,820
| Closed | -$708K | – | 1363 |
|
|
2017
Q4 | $708K | Buy |
245,820
+174,952
| +247% | +$636K | 0.02% | 465 |
|
|
2017
Q3 | $318K | Buy |
70,868
+4,165
| +6% | +$18.5K | 0.01% | 810 |
|
|
2017
Q2 | $306K | Sell |
66,703
-22,139
| -25% | -$89K | 0.01% | 759 |
|
|
2017
Q1 | $374K | Sell |
88,842
-106,307
| -54% | -$441K | 0.01% | 858 |
|
|
2016
Q4 | $806K | Buy |
195,149
+92,537
| +90% | +$492K | 0.02% | 474 |
|
|
2016
Q3 | $831K | Buy |
102,612
+82,766
| +417% | +$704K | 0.02% | 475 |
|
|
2016
Q2 | $155K | Sell |
19,846
-20,113
| -50% | -$173K | ﹤0.01% | 1463 |
|
|
2016
Q1 | $308K | Buy |
+39,959
| New | +$293K | 0.01% | 1280 |
|
|
2015
Q3 | – | Sell |
-10,400
| Closed | -$92K | – | 1834 |
|
|
2015
Q2 | $92K | Buy |
+10,400
| New | +$98.4K | ﹤0.01% | 1422 |
|
|
2015
Q1 | – | Sell |
-13,942
| Closed | -$171K | – | 1693 |
|
|
2014
Q4 | $171K | Sell |
13,942
-31,275
| -69% | -$382K | 0.01% | 1308 |
|
|
2014
Q3 | $451K | Buy |
45,217
+18,625
| +70% | +$173K | 0.02% | 743 |
|
|
2014
Q2 | $201K | Buy |
+26,592
| New | +$106K | 0.01% | 1049 |
|
|
2014
Q1 | – | Sell |
-48,767
| Closed | -$162K | – | 1492 |
|
|
2013
Q4 | $162K | Buy |
+48,767
| New | +$142K | 0.01% | 1137 |
|
Tudor Investment Corp's ACHN Position: Q1 2020 in Review
Tudor Investment Corp sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 90,270 shares — an estimated $544K sold.
Tudor Investment Corp first reported a position in ACHN in Q4 2013 and held it in 19 quarters. The position peaked at $831K in Q3 2016. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Tudor Investment Corp reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Tudor Investment Corp sold 90,270 Achillion Pharmaceuticals shares in Q1 2020, an estimated $544K.
- Tudor Investment Corp first reported a position in Achillion Pharmaceuticals in Q4 2013 and held it in 19 quarters.
- Tudor Investment Corp's Achillion Pharmaceuticals position peaked at $831K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Tudor Investment Corp's 13F filing for Q1 2020, filed 15 May 2020.